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Alcohol exposure during development can result in variable growth retardation and facial dysmorphology known as fetal alcohol
spectrum disorders. Although the mechanisms underlying the disorder are not fully understood, recent progress has been
made that alcohol induces aberrant changes in gene expression and in the epigenome of embryos. To inform the gene and
epigenetic changes in alcohol-induced teratology, we used whole-embryo culture to identify the alcohol-signature protein proﬁle
of neurulating C6 mice. Alcohol-treated and control cultures were homogenized, isoelectrically f o c u s e d ,a n dl o a d e df o r2 Dg e l
electrophoresis. Stained gels were cross matched with analytical software. We identiﬁed 40 diﬀerentially expressed protein spots
(P<0.01), and 9 spots were selected for LC/MS-MS identiﬁcation. Misregulated proteins include serotransferrin, triosephosphate
isomeraseandubiquitin-conjugatingenzymeE2N.Misregulationofserotransferrinandtriosephosphateisomerasewasconﬁrmed
with immunologic analysis. Alteration of proteins with roles in cellular function, cell cycle, and the ubiquitin-proteasome pathway
was induced by alcohol. Several misregulated proteins interact with eﬀectors of the NF-κB and Myc transcription factor cascades.
Using a whole-embryo culture, we have identiﬁed misregulated proteins known to be involved in nervous system development and
function.
1.Introduction
Fetal alcohol spectrum disorders (FASD) is characterized
by a multiorgan phenotype with various degrees of neural
developmental deﬁcit, growth retardation, microcephaly,
joint deformity, cardiac malformation, and facial dysmor-
phology due to alcohol exposure during pregnancy [1, 2]. A
continuum of deﬁcits aﬀecting multiple aspects of cognition
a n db e h a v i o ri ss e e ni nF A S D - a ﬀected children [3]. While
the underlying mechanism driving FASD remains unclear
[4–6], altered cellular pathways include cellular metabolism
[7–9], suppression of protein and DNA synthesis [10],
and oxidative stress [11]. Recent evidence suggests alcohol
induces aberrant epigenetic changes during neurogenesis,
when proper gene and protein expression plays a critical
role in neurodevelopment [12]. For example, we have found
aberrant DNA methylation results in the misexpression
of neurospeciﬁcation genes Ngn and Sox5 [12, 13]. Over
2,100 diﬀerentially methylated genes have been identiﬁed
in alcohol-treated embryos, suggesting that multiple cellular
pathways are likely to be altered at the protein level [13].
Ethanol has multiple eﬀects on methyl donors and
inhibits folate-mediated methionine synthesis [14], thereby
interrupting the substrate for biologic methylation. A cor-
relation between altered DNA methylation and the severity
of neural tube defects is seen in alcohol-treated embryos
[13]. Folate supplementation of FASD models can amelio-
rate alcohol-induced neural tube defects [15]a n dp r o t e i n
misregulation in the central nervous system (CNS) [16].
These results suggest methionine synthesis, subsequent DNA2 International Journal of Proteomics
methylation, and the resulting epigenome is critical for
normalembryonicdevelopment[14].Interestingly,ingravid
mice the methionine synthesis pathway is altered with iron
deﬁciency as well as alcohol exposure [17]. Iron deﬁciency
produces CNS defects, such as microencephaly and psy-
chomotor dysfunction, that parallel the defects seen in FASD
[18]. Ethanol also aﬀects the intracellular proteolytic path-
way, which is essential for cellular regulation and viability
[19]. The ubiquitin-proteasome system is the primary cellu-
lar pathway for degrading damaged proteins and controlling
the level of gene regulatory factors and has been implicated
in the etiology of alcoholic liver disease and neurode-
generative disease, including Alzheimer’s and Parkinson’s
disease [20]. Alcohol-fed rodents accumulate protein in the
liver, reﬂecting a decrease in hepatocyte catabolism [19],
ostensibly from downregulation of proteasome-interacting
proteins and regulatory complexes [21]. More signiﬁcantly,
microarray and proteomic analyses demonstrate reduced
expression of proteasome components in alcohol-exposed
embryonic mice [16, 22].
Previous gene expression and proteomic analyses of
FASD models have been completed, and the results generally
overlap. Microarray analysis of alcohol-exposed fetal brain
has demonstrated downregulation of genes involved in cell
proliferation, diﬀerentiation, apoptosis, and the ubiquitin-
proteasome pathway [23]. The identiﬁed genes have been
shown to contribute to tissue growth and remodeling, as
well as neuronal growth and survival. Gutala et al. [24]
demonstrated that alcohol treatment of mouse cortical
cells suppresses the expression of ubiquitin-proteasome
and ribosomal pathway genes, leading to disruption of
the protein degradation and protein synthesis machinery.
Green and colleagues [22] have shown that proteasome
and ribosome pathways are downregulated after 3 hours of
alcoholexposureatE8;conversely,cellularpathwaysinvolved
in tight junctions, focal adhesion, and regulation of the actin
cytoskeleton are upregulated at 3hrs. Similarly, proteomic
analyses have demonstrated alteration of proteins involved
in energy production, cellular signaling, protein translation,
and the ubiquitin-proteasome system [16]. Speciﬁc proteins
known to be alcohol-sensitive include brain-derived neu-
rotrophic factor (BDNF) [25], cellular retinoic acid binding
protein I (CRABP-I) [26], and proteasome subunit α type-
6[ 16]. Using embryonic cultures, we have previously found
upregulation of cyclin D1 and proapoptotic p53 [27].
In the current study, we have used an established whole-
embryo culture model with strictly controlled staging (timed
by somite number) and alcohol dose to obtain an alcohol-
signature protein proﬁle. This proﬁle may inform the gene
and epigenetic changes in alcohol-induced teratology and/or
lead to the development of biomarkers of prenatal alcohol
exposure. Previous research with this culture model has
demonstrated alcohol-induced abnormalities of the neural
tube, brain vesicles, optic system, heart, and limb buds [13].
Neural tube abnormalities occur most frequently in the head
fold and correlate with more severe genetic and pheno-
typic abnormalities. To characterize misregulated proteins
associated with these developmental abnormalities, we have
selected 2D gel electrophoresis to investigate the eﬀects of
alcohol exposure on the embryonic proteome. The feasibility
of whole-embryo 2D gel electrophoresis has been demon-
s t r a t e di np r e vi o u ss t u d i e s[ 28]. Based on our proteomic and
immunologic results, we conclude that the epigenetic and
morphologic changes induced by alcohol exposure results in
protein misregulation during neurulation.
2.MaterialsandMethods
2.1. Embryonic Culture. A whole-embryo culture model was
used to study alterations in protein regulation associated
with FASD. This FASD model has been described previously
by Ogawa et al. [29]. Brieﬂy, C57BL/6 (C6) mice (weighing
approximately 20g) were purchased from Harlan, Inc. (Indi-
anapolis, IN, USA). All animal procedures were approved
by the Indiana University Institutional Animal Care and
Use Committee. Mouse breeders were individually housed
and maintained on a 12 hour light-dark cycle (light on:
19:00–7:00) and provided laboratory chow and water ad
libitum. When a vaginal plug was detected after the mating
period, it was designated as gestational day 0 (GD0) or
embryonic day 0 (E0). On E8.25, dams were sacriﬁced by
overdose using CO2 gas. The technique for whole-embryo
culture was based on the method described by New [30].
Brieﬂy, the gravid uterus was removed and placed in a sterile
phosphate buﬀer containing saline (PBS, 0.1M) at 37◦C.
Decidual tissues and the Reichert membrane were removed
carefully and immediately immersed in the PBS containing
4% fetal bovine serum (Sigma, St. Louis, MO, USA), leaving
the visceral yolk sac and a small piece of the ectoplacental
cone intact. Three embryos bearing three to six somites were
placed in a culture bottle (20mL) containing the culture
medium, which consisted of 70% immediately centrifuged
heat-inactivated rat serum (Harlan Sprague-Dawley, Inc.)
and 30% PB1 buﬀer (137mM NaCl, 2.7mM KCl, 0.5mM
MgCl2,8m MN a 2HPO4,1 . 4 7m MK H 2PO4,0 . 9m MC a C l 2,
5.6mM glucose, and 0.33mM sodium pyruvate; pH 7.4).
The embryos were then supplemented with penicillin and
streptomycin (20 units/mL and 20μg/mL, resp., Sigma).
Bottles were gassed at 0 to 22hr with 5% O2,5 %C O 2,
and 90% N2 a n da t2 2t o4 4 h rw i t h2 0 %O 2,5 %C O 2,
and 75% N2 in a rotating culture system (B.T.C. Precision
Incubator Unit; B.T.C. Engineering, Cambridge, England;
36rpm) at 37◦C. After the preculture period (2–4hr; max-
imum, 4hr), alcohol exposure was started by transferring
the embryos into the medium containing 6μL/mL of 95%
ethanol (approximately 400mg/dL). Before the experiment,
the medium alcohol levels in the setting were tested using
an Analox alcohol analyzer (Analox Instruments USA,
Lunenburg, MA, USA). The control group was cultured
in the medium with no ethanol. On day 2, the culture
medium was changed 22hr after the start of the exposure
with the same treatments described above. All cultures were
terminated 44hr from the beginning of treatment. A total
of 73 embryos from 25 separate cultures were used in this
study. In each culture batch, control embryos were included
to avoid misinterpretations produced by any diﬀerences in
the cultural conditions among these experiments.International Journal of Proteomics 3
The concentration of ethanol in the medium across 24hr
wastested at0, 12, and22hr(thetiming ofmedium change),
previously, in a separate group not used for vulnerability
study [29]. The medium alcohol level used in current study
is comparable to the in vivo dosage for the lowest teratogenic
dose used by Webster et al. [31]. This level is considered
within the range attained by human alcoholics [32, 33].
At the end of culture, viability was conﬁrmed by blood
circulation of the yolk sac and cardiac activity. Embryos were
snap frozen in liquid N2.
2.2. 2D Gel Analysis. Frozen (−70◦C) embryos were pooled
(n = 7) in a 25mL beaker, along with 8 volumes of a
solution containing 9M urea, 4% Igepal CA-630 ([octylphe-
noxy] polyethoxyethanol), 1% dithiothreitol (DTT), and 2%
carrier ampholytes (pH 8–10.5), and thoroughly sonicated.
After solubilization at room temperature, samples were
centrifuged at 100,000 × g for 30min using a Beckman TL-
100 ultracentrifuge (Fullerton, CA, USA) to remove nucleic
acid and insoluble materials; the supernatants were stored
at −45◦C until 2DE separation. Using overnight, passive
rehydration at room temperature, homogenized sample
was loaded onto immobilized pH-gradient (IPG) strips
(24cm, nonlinear pH 3–10: BioRad: Hercules, CA, USA).
Isoelectric focusing (IEF) was performed with a Protean
IEF Cells (BioRad) (10 strips/instrument), by a program
of progressively increasing voltage for a total of 100,000
Vhr. A computer-controlled gradient casting system was
used to prepare second-dimension (2D) sodium dodecyl
sulfate (SDS) gradient slab gels (20 × 25 × 0.15cm) in
which the acrylamide concentration varied linearly from
11% to 17% T. First-dimension IPG strips were loaded
directly onto the slab gels following equilibration for 10min
in buﬀer I. All nine 2D slab gels were run in parallel at
8◦C for 18h at 160V and subsequently ﬁxed and stained
using a sensitive colloidal Coomassie Blue G-250 procedure
[34]. After 96h, gels were washed several times with water
and scanned at 95.3μm/pixel resolution using a GS-800
Calibrated Imaging Densitometer (Bio-Rad). The resulting
12 bit images were analyzed using PDQuest software (Bio-
Rad, v.7.1). Background was subtracted and protein spot
density peaks detected and counted. Because total spot
counts and the total optical density are directly related to
the total protein concentration, individual protein quantities
were thus expressed as parts-per-million (ppm) of the total
integrated optical density, after normalization against total
image density. A reference pattern was constructed and each
of the gels in the match set was matched to the reference
gel. Numerous proteins that were uniformly expressed in
all patterns were used as landmarks to facilitate rapid gel
matching. Protein spots that were not present in at least 3
of the gels for both groups were removed from the analyses.
A statistical mean was determined for each spot in both the
alcohol-treated and control groups. A t-test was performed
between the two groups to determine which spots had a
signiﬁcantly diﬀerent staining intensity (P<0.01). Protein
spots were excised from the gels and destained with ace-
tonitrile (ACN) in 50mM NH4HCO3, reduced with 10mM
DTT, alkylated with iodoacetamide, and in-gel digested
with modiﬁed trypsin at 37◦C overnight, followed by serial
extraction with ACN. Tryptic peptides were analyzed on a
LTQ mass spectrometer (Thermo Electron, San Jose, CA,
USA) coupled with an Agilent 1100 HPLC system (Agilent
Technologies, Santa Clara, USA) and C18 nanocolumn
(75μm × 5cm). Peptides were eluted with a linear gradient
from 5 to 45% acetonitrile developed over 60min at a ﬂow
rate of 300nL/min. The acquired MS/MS data were ﬁltered
and analyzed by a proprietary algorithm [35]. Database
searches against the IPI (International Protein Index) mouse
databaseandthenonredundantmousedatabasewerecarried
out using both the X!Tandem and SEQUEST algorithms.
2.3. Ingenuity Pathways Analysis. Identiﬁed proteins were
submitted to Ingenuity Pathways Analysis (IPA) (Ingenuity,
Inc. http://www.ingenuity.com) online software. IPA builds
networks based upon information extracted from the sci-
entiﬁc literature and deposited in the Ingenuity Knowledge
Base. IPA provides an assessment of the signaling and
metabolic pathways, molecular networks, and biological
processes that are most signiﬁcantly perturbed in the exper-
imental condition. The Path Designer feature was utilized to
abridge the molecular network for publication.
2.4. Western Blot Analysis. Western blotting was used to
conﬁrm the misregulation of proteins of mechanistic interest
in FASD, as previously described [27]. For total protein
procurement, 3 embryos were pooled as one sample.
Homogenized embryos were loaded on two, 8–12% PAGE
gels. Proteins were transferred to a nitrocellulose membrane
and blocked overnight with 5% milk and 0.02% BSA,
washed 3× in TBST, then incubated for 2–4h at 30◦C using
the appropriate 1◦ antibody. Primary antibodies included:
goat poly (rC)-binding protein 1, rabbit serotransferrin
and triosephosphate isomerase (Santa Cruz Biotechnology),
and mouse Ube2N (Abcam). Monoclonal anti-GAPDH-
peroxidase (Sigma) (1:40,000 dilution) was incubated as
internal control for densitometry. Membranes are washed
and incubated with the appropriate HRP conjugated 2◦ anti-
body and detected with a Pierce ECL detection kit (Thermo
Fisher Scientiﬁc, Rockford, IL, USA). Blots are detected
with a FOTO/Analyst Luminary/FX system (FOTODYNE
Inc., Hartland, WI, USA), and densitometric comparisons
were made with TotalLab Quant software (v.11.5). GAPDH
density measurements were used for load controls, and
variations in measurements were adjusted by percentage
to the highest values for that membrane. Measurements
for each target protein were then adjusted in accordance
with the GAPDH load controls. All changes in protein
expression from alcohol treatment are reported as a per-
centage change compared to controls, with a minimum of 3
samples/treatment group. Statistical analysis used Student’s
t-test on Microsoft Excel (v. 14).
2.5. Immunohistochemistry Analysis. The embryos of the
two treatment groups (alcohol = 4, control = 4e m b r y o s )
were paired and embedded in gelatin together at E10.25,4 International Journal of Proteomics
with careful alignment of their level and orientation.
They were sectioned in 40 micron and processed for
immunohistochemistry in parallel; this practice avoids any
bias through the staining procedure and is convenient
for comparing levels of embryo sections side by side. All
sections were then washed 3× in PBS. They were then
incubated in (1) 3% H2O2 (v/v) in PBS for 30 minutes
and (2) PBS containing 4% normal control serum, and
0.3% Triton X-100 (TX) for 30 minutes at room tem-
perature to block nonspeciﬁc binding. Sections were next
incubated with antibodies against serotransferrin (1:50)
and triosephosphate isomerase (1:50). All 1◦ antibodies
were incubated overnight at room temperature. The sections
were then incubated with a 2◦ antibody (1:250, Jackson
ImmunoResearch Laboratory, West Grove, PA) for 1hr,
followed by an avidin-biotin peroxidase complex (Vector
Laboratories)for1hratroomtemperature.Allsectionswere
washed 3× with PBS for 5 minutes between each antibody
incubation. The color reaction (brown) was developed by
adding 0.05% 3  to 3 -diaminobenzidine tetrahydrochloride
and 0.003% H2O2 in Tris buﬀer to reveal the peroxidase
activity.
3. Results
3.1. Embryonic Growth Retardation/Abnormalities. Among
all cultured embryos, more than 95% maintained active
heartbeats and blood circulation during the incubation
period, and only those were used for analysis. Control and
alcohol-treated embryos are shown in Figure 1. Embryonic
development was signiﬁcantly compromised by alcohol-
exposure, consistent with previous studies [12, 13, 36, 37].
Growth retardation and abnormalities of the brain, heart,
and limbs were seen in alcohol-treated embryos. Speciﬁc
abnormalities include neural tube defects, heart malforma-
tions, small/slanted eyes, abnormal tail morphology, and
unﬁnished turning of the neural axis. A reduced blood/
vascular system with less yolk sac vascularity and a lower red
coloration was apparent in the alcohol-treated versus control
embryos.
3.2. 2D Gel Analysis. The total number of gel spots detected
by PDQuest was 2,050. Forty gel spots with signiﬁcant (P<
0.01) diﬀerential expression (>1.5-fold change) between
alcohol-treated and control embryos were identiﬁed. Inte-
grated densities of 8 gel spots fell below 200ppm, a protein
density that is too low for reliable MS/MS identiﬁcation.
Of the remaining 32 spots, 24 were downregulated and 8
were upregulated in alcohol-treated embryos. To prioritize
the study, only those spots with a highly signiﬁcant (P<
0.007) diﬀerence in expression levels were selected for
analysis. Five downregulated and 4 upregulated spots were
selected for LC-MS/MS identiﬁcation (Figure 2). Table 1 lists
the numerical assignment, number of peptides used for
identiﬁcation,UniProtKBaccessionnumber,genename,and
the protein identiﬁcation for each spot with a signiﬁcant
(P<0.007) diﬀerence in expression levels between the two
groups.
Control
Control
Alcohol-NTC
Alcohol-NTO
HB
HB MB
FB
H H
MB
FB
Figure 1: Alcohol-induced dysmorphology of embryonic devel-
opment at E10.25. The alcohol-treated embryos (right side of
ﬁgure) showed developmental delay and abnormalities. Examples
are demonstrated in small forebrain (FB), midbrain (MB), or
hindbrain (HB); abnormality of the heart (H); small eyes (black
arrows) as compared with control (left). A reduced blood/vascular
system with lower red coloration was apparent in the alcohol-
treated embryos. A major dichotomic phenotype is embryos with
neural tube closed but with delay and abnormality in development
(Alcohol-NTC), and neural tube opened (Alcohol-NTO). An open
neural tube is shown (red arrows) in an alcohol-treated embryo
(bottom right). Scale bar: 1,000 micron.
3.3. Western Blot Analysis. Western blot image density anal-
ysis conﬁrmed upregulation of serotransferrin (Tf) and
triosephosphate isomerase (Tpi1) (P<0.05) (Figure 3). Poly
(rC)-binding protein 1 (Pcbp1) and ubiquitin-conjugating
enzymeE2N(Ube2N)aredownregulatedon2Dgelanalysis,
but this was not statistically signiﬁcant by Western blot
densitometry. The Ube2n band is faint.
3.4. Immunohistochemistry. Immunostaining (im) of E10.25
embryos demonstrated upregulation of Tf and Tpi1 in
alcohol-treated embryos. Tf-im consistently localized to the
heart, branchial arches and somites of treated embryos rel-
ative to control (Figure 4). Tpi1-im was diﬀusely increased;
however, this staining pattern was less consistent among
treated embryos.
3.5. Ingenuity Pathways Analysis. Nine proteins identiﬁed by
LC-MS/MS were submitted to IPA to assess the biological
networks perturbed by alcohol treatment (Figure 5). The top
reported networks were cell cycle, cell death, gene expression
and reproductive system development and function. The
top reported biological functions were antigen presentation,
cell cycle, cellular signaling, cellular function and main-
tenance, hematopoiesis, and immune cell traﬃcking. TheInternational Journal of Proteomics 5
Table 1: Protein identiﬁcation of diﬀerentially expressed spots from 2D gel analysis of alcohol-treated embryos. The spot assignments,
number of peptides used for identiﬁcation, UniProtKB accession number, gene name, and the protein identiﬁcation for each spot. Proteins
are grouped by their pattern of expression (up- or downregulated) in alcohol-treated embryos relative to control.
Spot ID No. peptides Accession Gene ID Protein ID
Proteins upregulated in alcohol-treated embryos
5829 54 Q921I1 Tf Serotransferrin precursor
8217 9 Q9WVA4 Tagln2 Transgelin-2
4601 8 Q9QZ83 Actg1 Gamma actin-like protein
7324 5 P17751 Tpi1 Triosephosphate isomerase
Proteins downregulated in alcohol-treated embryos
7605 54 P60335 Pcbp1 Poly (rC)-binding protein 1
4424 36 P70195 Psmb7 Proteasome subunit β
type-7
4110 21 P61089 Ube2n Ubiquitin-conjugating
enzyme E2 N
7013 16 Q9CQW5 Lgals2 Galectin-2
5112 7 Q99L47 St13 Hsc70-interacting protein
4
30
42
36
16
23
26
8 7 5 6 6.5
Pi
kDa
Tagln2
Actg1
Tagln2 Tagln
Tf
Pcbp1
Lgals2
Psmb7
St13
Tpi1
Ube2N
Figure 2: Sample 2D gel separation of whole-embryo proteins.
Whole-embryos were solubilized and the proteins separated using
IPG strips in the 1st dimension and SDS gradient slab gels in the
2nd dimension. The protein proﬁles were visualized by Coomassie
blue staining. Nine MS/MS identiﬁed protein spots with diﬀerential
expressionduetoalcoholtreatmentarehighlightedwithawhite“x”
and labeled with the gene name. The remaining spots with altered
expression are labeled with the spot number in black font followed
by “R,” signifying this gel as the reference (R) control.
top canonical pathways aﬀected by alcohol treatment are
clathrin-mediated endocytosis signaling and the ubiquitin-
proteasome pathway.
4. Discussion
Thisstudywasdesignedtocharacterizethealcohol-signature
protein proﬁle of a whole-embryo culture model of FASD.
Thewhole-embryowasstudiedatanearly,neurulatingstage,
and the resulting protein proﬁle represents an average across
all cell types and tissues. While the embryo system is less
sensitive for identifying misregulated proteins in individual
organs, our results clearly demonstrate that this model is
sensitive for detecting systemic protein misregulation. The
analysis detected 40 diﬀerentially expressed protein spots,
and 9 spots were identiﬁed by MS/MS. The possibility
exists that some of these protein expression changes may be
posttranslational modiﬁcations (PTM); nevertheless, these
PTM might be important to the pathology of FASD and
could be characterized in subsequent studies.
The abnormal embryonic development resulting from
the alcohol treatment is consistent with our previous report
[29]. The aﬀected structures were derived from each of the
three germ layers and involve a wide range of tissues and
organs. These eﬀects on protein regulation may parallel the
growth delay and developmental abnormalities including
brain, neural tube, eye, heart, blood cells, and embryonic
vascularization, which are major targets in FASD [13].
As explained in the methods section, 9 diﬀerentially
expressed proteins were submitted for Ingenuity analysis.
Perturbations in cellular function and maintenance, cell
cycle, and the ubiquitin-proteasome pathway were demon-
strated by Ingenuity. Biological functions altered by alcohol
include hematopoiesis and clathrin-mediated endocytosis.
We have previously conﬁrmed absent expression of 4 key
hematopoietic genes (Add2, B2m, Cp,a n dGpa), along
with an embryonic phenotype consistent with reduced
hematopoiesis in alcohol-exposed embryos [12]. Previ-
ous studies have demonstrated perturbations of clathrin-
mediated endocytosis in adult rat brain extracts [38];
this may result in alterations of postsynaptic plasticity.
The Ingenuity molecular network (Figure 5) suggests that
the NF-κB cascade and transcription factor Myc may be
speciﬁcally involved in the pathogenesis of FASD. Five
ethanol sensitive proteins interact with Protein IKBKE, a
kinase that phosphorylates inhibitors of NF-κB and leads6 International Journal of Proteomics
Ube2N
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(b)
Figure 3: Misregulated proteins of mechanistic interest in FASD were conﬁrmed with Western blotting. Both alcohol and control protein
(20μg) samples were run on SDS-PAGE gels and detected by chemical luminescence. GAPDH was used as an internal control. Statistical
analysis of band density by Student’s t-test showed that alcohol upregulates serotransferrin (Tf) and triosephosphate isomerase (Tpi1)
(P ≤ 0.05).
to NF-κBa c t i v a t i o n[ 39]. The transcription factor NF-
κB protects cells against DNA damage-induced cell death
and may play a role in the immune response. Alcohol
diﬀerentially regulates NF-κB activity in various tissues [40].
Ethanol activates NF-κB in cerebral vascular muscle cells
[41], in contrast, ethanol diminishes NF-κBt a r g e tg e n e
expression in fetal rhombencephalic neurons via a 5-HT(1A)
(serotonin) mediated pathway [42]. Ethanol also interferes
with inﬂammatory cytokine production by downregulat-
ing NF-κB in monocytes, resulting in impaired immunity
[42, 43]. The transcription factor Myc activates growth-
related genes [39]. Figure 5 shows that Pcbp1 and Tagln2
directly bind with Myc. Ethanol can induce release of
intracellular calcium that stimulates the cell cycle and the
expression of Myc proteins associated with cell proliferation.
Increased proliferation is advantageous during reimplanta-
tion, but ethanol interference with terminal diﬀerentiation
during organogenesis may underlie alcohol teratogenicity
[44].
Serotransferrin (Tf) is upregulated by proteomic and
immunologic analysis (Figures 2–4), which may be a com-
pensatory response to the altered iron regulation seen with
alcohol exposure. Tf transports iron from tissue sites of
absorption to sites of storage or utilization and has a role
in stimulating cell proliferation [39]. Because iron is an
essential cofactor in neurotransmitter synthesis and myeli-
nation, maternal iron status is an important modulator of
fetal alcohol-induced neurobehavioral damage [45, 46].
Interestingly, fetal alcohol syndrome produces defects that
parallel the abnormalities of early iron deﬁciency, including
microcephaly and motor and behavioral deﬁcits [18]. Our
observation that Tf localizes to the heart, branchial arches
and somites with alcohol treatment is interesting (Figure 4).
These ﬁndings warrant further investigation into the associ-
ation between altered iron regulation, cardiac malformation,
and FASD.
Protein triosephosphate isomerase (Tpi1) and transgelin
(Tagln2) were upregulated in our proteomic analysis. Tpi1
misregulation was conﬁrmed with Western blot. Diﬀuse
Tpi1-im was seen on whole-embryo immunohistochemistry
(Figure 4). Our previous proteomic analysis demonstrated
upregulation of Tpi1 in the nucleus accumbens of alcohol-
exposed adult rats [47]. Green et al. noted upregulation
of pentose phosphate pathway genes in alcohol-exposed C6
mouse embryos [22]. Tpi1 is an enzyme of the pentose phos-
phate pathway that binds to microtubules and other subcel-
lular components. Protein Tpi1 can reduce the enzymatic
activity of other metabolic proteins when bound to them
[48]. Tagln2 is one of the earliest markers of diﬀerentiated
smooth muscle. The function of Tagln2 has not yet been
determined,butproteomicanalysishasdemonstratedaltered
regulation during neurulation [49, 50].
The protein ubiquitination pathway targets molecules
for proteasomal degradation through conjugation with
Lys48-linked ubiquitin. Alternatively, proteins modiﬁed with
Lys63-linked ubiquitin chains play roles in signal trans-
duction through the NF-κB cascade, receptor endocytosis,
and DNA-repair processes [51]. Degradation of damaged
proteins is critical for cellular viability, and evidence suggests
ethanol can downregulate components of the ubiquitin-
proteasome system [19]. Previous studies have shown that
proteasome β type-7 is downregulated at the gene and
proteinlevelinamurinemodelofFASD[16,22].Our2Dgel
analysis also demonstrates downregulation of proteasome β
type-7. This proteasome subunit forms the catalytic core of
the 26S proteasome [19], the main mechanistic component
of intracellular proteolysis.International Journal of Proteomics 7
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Figure 4: Immunolocalization of serotransferrin to the heart,
branchial arches and somites with alcohol treatment. Serotrans-
ferrin immunostaining (Tf-im) (a,b,c,d) and triosephosphate iso-
merase immunostaining (Tpi1-im) (e,f) are increased in alcohol-
treated embryos at E10.25. Tf-im consistently localized to the heart
(dotted region), branchial arch 1 (BA1) and somites (somites)
of alcohol-treated embryos (a) relative to control (b). High
magniﬁcation of the dotted region is shown in (c) (Alcohol) and
(d) (Control). Tpi1-im was diﬀusely increased in alcohol-treated
embryos (e) relative to control (f), but the staining pattern was less
consistent.
Our 2D gel analysis demonstrated downregulation of
ubiquitin-conjugating enzyme E2 N (Ube2N) with alcohol-
exposure, congruent with our previous analysis of adult
rat brain extracts [47]. A gene expression analysis demon-
strated that Ube2b, a member of the ubiquitin-conjugating
enzyme family, was downregulated in neurulating embryos
[12]. Ube2N and Ube2b both catalyze the synthesis of
Lys63-linked poly-ubiquitin chains and are involved in the
postreplication repair of damaged DNA. Interestingly, a
Drosophila homolog of Ube2N was originally isolated as
bendless protein, whose mutation aﬀects neuronal synaptic
connectivity and visual system development [52–54]. As
shown in Figure 5, Ube2N binds with inhibitor of nuclear
factor kappa-B kinase subunit ε (Protein IKBKE), a kinase
Tagln2
Pcbp1
Pabpc1
Psmd6
Psmb7
Retinoic acid Actg1
Ube2n
Ikbke
Ifng
Krt72
Trf
Tpi1
Myc
St13
Cdkn2a
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Figure 5: Ingenuity Pathways Analysis of misregulated pro-
teins from alcohol-treated whole-embryo culture. Proteins with
altered regulation were analyzed with Ingenuity Pathways Anal-
ysis online software. This Core Analysis highlights the signal-
ing and metabolic pathways, molecular networks, and biological
processes that are most signiﬁcantly perturbed in the alcohol-
treated cultures. The Ingenuity Path Designer feature was utilized
to abridge the molecular network. The proteins are represented
by shapes that reﬂect protein function (https://analysis.ingenu-
ity.com/pa/info/help/help.htm#legend.htm) and labeled with their
gene name. Proteins identiﬁed in alcohol-treated embryos have
shaded shapes; molecules not identiﬁed in this study have clear
shapes. These molecules were included in the abridged network
if they were linked to multiple identiﬁed proteins or formed
integral links between identiﬁed proteins. Solid lines indicate direct
interactions and dashed lines are indirect interactions. Abbrevi-
ations: Actg1—Gamma actin; Cdkn2a—Cyclin-dependent kinase
inhibitor2A;Ifng—Interferongamma;Ikbke—Inhibitorofkappab
kinase epsilon; Krt72—Keratin 72; Myc —v-myc myelocytomatosis
viraloncogenehomolog(avian);Pabpc1—poly(A)bindingprotein,
cytoplasmic 1; Pcbp1—poly(rC) binding protein 1; Psmb7—
Proteasome subunit β type 7; Psmd6—Proteasome 26S sub-
unit, non-ATPase, 6; St13— Hsp70 interacting protein; Tagln2—
Transgelin 2; Trf (Tf)—Serotransferrin; Tpi1—Triosephosphate
isomerase 1; Ube2n—Ubiquitin-conjugating enzyme E2N.
that activates the NF-κB pathway. The Western blot analysis
demonstrated a faint band at the expected molecular weight
of Ube2N (∼17kDa) (Figure 3). Ube2N gene expression
is temporally regulated during development [55], and our
results suggest that Ube2N protein is only marginally
expressed at E10.
Hypoxia and ischemia regulate the expression of several
important genes at the level of transcription and of mRNA
stability. An isoform of poly (rC)-binding protein (Protein
Pcbp1), previously identiﬁed as an RNA-binding protein,
binds to a hypoxia-inducible protein-binding site in the
3  region of erythropoietin mRNA and regulates stability
[56, 57]. Protein Pcbp1 is downregulated in our proteomic
analysis; however, Western blot did not demonstrate signiﬁ-
cant misregulation. The embryonic phenotype is consistent
with reduced hematopoiesis in this FASD model [12].8 International Journal of Proteomics
Since Pcbp1 protects erythropoietin mRNA, we hypothesize
that downregulation of Pcbp1 may be the mechanism for
decreased hematopoiesis.
Galectin-2, which is expressed in diﬀerentiated enteric
tissue [58], is downregulated in our analysis. Previous
experiments in Xenopus embryos have shown that alcohol
exposure causes fetal enteric damage and reduced body
length [59]. We hypothesize that downregulation of galectin-
2 in our FASD model reﬂects gut underdevelopment.
In summary, alcohol exposure during the period of early
neurulation results in an alcohol-signature protein proﬁle.
This proﬁle should contribute to (1) generation of testable
new hypotheses concerning the mechanistic pathway from
protein misregulation to alcohol-induced teratogenesis and
(2) development of clinical biomarkers of prenatal alcohol
exposure. We identiﬁed proteins (serotransferrin, Ube2N)
known to be involved in development of the nervous system,
and that the NF-κB cascade and the transcription factor Myc
may be speciﬁcally involved in alcohol-induced teratology.
These misregulated proteins may reﬂect altered cellular
pathways secondary to epigenetic, posttranscriptional, or
morphologic changes.
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